T/CLPA 003-2023 English Version, T/CLPA 003-2023 Guidelines for Pharmaceutical Care of Endocrine Therapeutics for Breast Cancer (2023 Edition) (English Version)

Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

T/CLPA 003-2023 Guidelines for Pharmaceutical Care of Endocrine Therapeutics for Breast Cancer (2023 Edition) (English Version)
Standard No.:	T/CLPA 003-2023	Status:	valid remind me the status change Email:
Target Language:	English	File Format:	PDF
Word Count:		Translation Price(USD):	remind me the price change Email:
Implemented on:	2023-11-22	Delivery:

→

Standard No.:	T/CLPA 003-2023
English Name:	Guidelines for Pharmaceutical Care of Endocrine Therapeutics for Breast Cancer (2023 Edition)
Chinese Name:	乳腺癌内分泌治疗药物药学服务指南
Chinese Classification:	C15 Drugs for hormone, family planning, antineoplastic and immunosuppression
Professional Classification:	T/ Social Organization Standard
Source Content Issued by:	China Pharmacist Association
Issued on:	2023-11-22
Implemented on:	2023-11-22
Status:	valid
Target Language:	English
File Format:	PDF

Standard

T/CLPA 003-2023 Guidelines for Pharmaceutical Care of Endocrine Therapeutics for Breast Cancer (2023 Edition) (English Version)
Standard No.	T/CLPA 003-2023
Status	valid
Language	English
File Format	PDF
Word Count	words
Price(USD)
Implemented on	2023-11-22
Delivery	via email in business day

Detail of T/CLPA 003-2023

Standard No.

English Name

Chinese Name

Chinese Classification

Professional Classification

ICS Classification

Issued by

Issued on

Implemented on

Status

Superseded by

Superseded on

Abolished on

Superseding

Language

File Format

Word Count

Price(USD)

Keywords

Introduction of T/CLPA 003-2023

本文件涵盖了截至2023年6月1日国家药品监督管理局(NationalMedical Products Administration，NMPA)已批准的56个乳腺癌内分泌治疗相关药物(含通过一致性评价的仿制药)的全程化药学服务的内容。本文件适用于所有开展乳腺癌内分泌治疗药物药学服务的医疗机构。

Contents of T/CLPA 003-2023

Tel: +86-10-8572 5655 \| Fax: +86-10-8581 9515 \| Email: coc@codeofchina.com \| QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040



Keywords:
T/CLPA 003-2023, T/CLPAT 003-2023, TCLPAT 003-2023, T/CLPA003-2023, T/CLPA 003, T/CLPA003, T/CLPAT003-2023, T/CLPAT 003, T/CLPAT003, TCLPAT003-2023, TCLPAT 003, TCLPAT003